Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • frymor
    Senior Member
    • May 2010
    • 151

    bowtie output

    Hi,

    I'm running bowtie with this command:
    bowtie -a --best --strata -m 10 -n 2 -l 22 -q --un mut.unmapped -t -p 2 -5 11 --chunkmbs 256 --max mut.maxHits -S d_melanogaster_fb5_32 -1 s2_1_sequence.fq -2 s2_2_sequence.fq output.sam
    this what I am getting on my output when I am running bowtie:
    Time loading reference: 00:00:01
    Time loading forward index: 00:00:01
    Time loading mirror index: 00:00:01
    Seeded quality full-index search: 05:03:50
    # reads processed: 42867915
    # reads with at least one reported alignment: 21891058 (51.07%)
    # reads that failed to align: 20748783 (48.40%)
    # reads with alignments suppressed due to -m: 228074 (0.53%)
    Reported 23418877 paired-end alignments to 1 output stream(s)
    Time searching: 05:03:53
    Overall time: 05:03:53
    For each of the paired-end fastq files I have 42867915 reads. this is also the sum of the three #-lines.
    What is the meaning of the number in the last line? -23418877

    Thanks
    Assa
  • andrehorta
    Member
    • Jan 2011
    • 14

    #2
    I don't know too.

    Process C:/ufmg/brca_diagnostic/FASTQ/SRR062634.filt.fastq
    # reads processed: 308846
    # reads with at least one reported alignment: 833 (0.27%)
    # reads that failed to align: 308013 (99.73%)
    Reported 833 alignments to 1 output stream(s)
    # reads processed: 308846
    # reads with at least one reported alignment: 794 (0.26%)
    # reads that failed to align: 308052 (99.74%)
    Reported 794 alignments to 1 output stream(s)
    Look for mutations...

    Comment

    • csoong
      Member
      • Jun 2009
      • 74

      #3
      Seems like some PE-reads were mapped to more than 1 location but below your "m" threshold.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      213 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      79 views
      0 reactions
      Last Post SEQadmin2  
      Working...